To test this hypothesis, we evaluated the effect of DSP, a small peptide molecule, that unlike anti‐PAI‐1 mAbs interacts with the enzyme, on the outcomes of fibrinolytic therapy with sctPA and scuPA in rabbit models of chemically induced and infectious pleural injury. This evidence concerns the gene SERPINE1 and injury.